CDKN2 Gene Deletion as Poor Prognosis Predictor Involved in the Progression of Adult B-Lineage Acute Lymphoblastic Leukemia Patients

Deletion of cyclin-dependent kinase inhibitor 2A/B (CDKN2A/B) is well known in many hematologic malignancies, but only few reports have investigated this deletion effect on clinical prognosis. This study performed analysis of the CDKN2 deletion in 215 adult B- lineage acute lymphoblastic leukemia (B...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Na, Li, Yu-ling, Zhou, Xuan, Cao, Rui, Li, Huan, Lu, Qi-si, Li, Lin, Lu, Zi-yuan, Huang, Ji-xian, Sun, Jing, Liu, Qi-fa, Du, Qing-feng, Liu, Xiao-li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615347/
https://www.ncbi.nlm.nih.gov/pubmed/26516359
http://dx.doi.org/10.7150/jca.11959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615347/
https://www.ncbi.nlm.nih.gov/pubmed/26516359
http://dx.doi.org/10.7150/jca.11959

Ejemplares similares